SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative ligand 1376
Kalnins, G.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| 2'-O-methyltransferase nsp16 | 302 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  Gene Names: rep, 1a-1b EC: 2.1.1.57 | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P0DTD1 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Non-structural protein 10 | 142 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P0DTC1 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 3 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| A1KOW( Subject of Investigation/LOI) Download:Ideal Coordinates CCD File | C [auth A] | 3-[[(2~{S},6~{R})-6-(6-aminopurin-9-yl)morpholin-2-yl]methylsulfanylmethyl]benzoic acid C18 H20 N6 O3 S WKQAPDQFMAZIBN-UONOGXRCSA-N | |||
| MES Download:Ideal Coordinates CCD File | D [auth A] | 2-(N-MORPHOLINO)-ETHANESULFONIC ACID C6 H13 N O4 S SXGZJKUKBWWHRA-UHFFFAOYSA-N | |||
| ZN Download:Ideal Coordinates CCD File | E [auth B], F [auth B] | ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 168.69 | α = 90 |
| b = 168.69 | β = 90 |
| c = 51.99 | γ = 120 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| xia2 | data reduction |
| Aimless | data scaling |
| MOLREP | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| Not funded | -- |